Project description
New solution brings relief to chronic lung disease sufferers
The EU-funded STOP-COPD project has developed a novel device, called PulseHaler™, to treat chronic obstructive pulmonary disease (COPD), a progressive disease of the lungs. The device successfully opens the small airways, which are known to collapse in COPD patients, making it difficult for them to breathe. PulseHaler™ improves the exercise capacity, reduces breathlessness, and improves quality of life of COPD sufferers. Researchers will optimise the device with new features and functions and prepare it for large-scale manufacturing. Given the millions of COPD patients in Europe alone, the device has the potential to substantially reduce associated healthcare costs.
Fields of science
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
RESPINOVA LTD
Net EU contribution
€ 2 414 365,63
Address
8 Hachoshlim St.
4672408 Herzliya Pituach
Israel
4672408 Herzliya Pituach
Israel
See on map
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 1 034 728,12